Diferencia entre revisiones de «Template:CMV neurologic disease treatment»
Sin resumen de edición |
(Strip translate tags to enable SMW subobject creation) |
||
| (No se muestran 2 ediciones intermedias de 2 usuarios) | |||
| Línea 1: | Línea 1: | ||
*{{AntibioticDose|disease=CMV neurologic disease|drug=Ganciclovir|dose=5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs|context=Combined with Foscarnet|population=Adult}} + | |||
**{{AntibioticDose|disease=CMV neurologic disease|drug=Foscarnet|dose=90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs|context=Combined with Ganciclovir|population=Adult}} | |||
* | |||
** | |||
Revisión actual - 02:54 20 mar 2026
- Ganciclovir 5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs +
- Foscarnet 90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs
